Osteogenic Growth Peptide (10-14) - CAS# 105250-85-9 246 9(12):e112925

9(12):e112925

Human β-amyloid interacts with zinc ions through its metal-binding domain 1-16

It is an orally administered agent with a similar antimicrobial spectrum to the intravenous agents cefalotin and cefazolin

is a dual antagonist of α4β7 and α4β1 integrins

InChiKey: QQUHMASGPODSIW-ICECTASOSA-N

Osteogenic Growth Peptide (10-14) - CAS# 105250-85-9 246 9(12):e112925Osteogenic Growth Peptide (10 14) (OGP(10 14)), the C terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP like activity. Osteogenic Growth Peptide (10 14) is responsible for the binding to the OGP receptor and activates an intracellular Gi protein MAP kinase signaling pathway. Osteogenic Growth Peptide (10 14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10 14)